Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jps Sawhney

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of the Association of Physicians of India|July 18, 2019
Appropriate use of PCSK9 Inhibitors in IndiaS S Iyengar, Manish Bansal, Jps Sawhney, et al.
The Journal of the Association of Physicians of India|July 3, 2020
Screening for Hypertension in Asymptomatic Individuals in India: An Expert Consensus StatementJamshed Dalal, K K Sethi, Santanu Guha, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
A Randomized Feasibility Trial of a Multicomponent Quality Improvement Strategy for Chronic Care of Cardiovascular Diseases: Findings from the C-QIP Trial in IndiaKavita Singh, Ambuj Roy, Dimple Kondal, et al.
The Journal of the Association of Physicians of India|June 24, 2023
Role of Iron Therapy in Heart Failure: A Consensus Statement from IndiaH K Chopra, G S Wander, Tiny Nair, et al.
The Journal of the Association of Physicians of India|June 25, 2023
Angiotensin Receptor-Neprilysin Inhibitor Therapy and Cardiac Remodeling in Heart Failure: Consensus Statement from IndiaH K Chopra, G S Wander, Tiny Nair, et al.
The Journal of the Association of Physicians of India|May 13, 2024
The Promise of Cilnidipine in Hypertension with Comorbidities: National Consensus Statement: National Consensus Group Comprises Cardiologists, Nephrologists, and Diabetologists from India in a National Meet at New Delhi held on 22<sup>nd</sup> May 2022Hirday Kumar Chopra, Gurpreet S Wander, Chandrashekhar K Ponde, et al.
The Journal of the Association of Physicians of India|June 17, 2024
Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney DiseaseH K Chopra, Dinesh Khullar, Tiny Nair, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of the Association of Physicians of India|July 18, 2019
Appropriate use of PCSK9 Inhibitors in IndiaS S Iyengar, Manish Bansal, Jps Sawhney, et al.
The Journal of the Association of Physicians of India|July 3, 2020
Screening for Hypertension in Asymptomatic Individuals in India: An Expert Consensus StatementJamshed Dalal, K K Sethi, Santanu Guha, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
A Randomized Feasibility Trial of a Multicomponent Quality Improvement Strategy for Chronic Care of Cardiovascular Diseases: Findings from the C-QIP Trial in IndiaKavita Singh, Ambuj Roy, Dimple Kondal, et al.
The Journal of the Association of Physicians of India|June 24, 2023
Role of Iron Therapy in Heart Failure: A Consensus Statement from IndiaH K Chopra, G S Wander, Tiny Nair, et al.
The Journal of the Association of Physicians of India|June 25, 2023
Angiotensin Receptor-Neprilysin Inhibitor Therapy and Cardiac Remodeling in Heart Failure: Consensus Statement from IndiaH K Chopra, G S Wander, Tiny Nair, et al.
The Journal of the Association of Physicians of India|May 13, 2024
The Promise of Cilnidipine in Hypertension with Comorbidities: National Consensus Statement: National Consensus Group Comprises Cardiologists, Nephrologists, and Diabetologists from India in a National Meet at New Delhi held on 22<sup>nd</sup> May 2022Hirday Kumar Chopra, Gurpreet S Wander, Chandrashekhar K Ponde, et al.
The Journal of the Association of Physicians of India|June 17, 2024
Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney DiseaseH K Chopra, Dinesh Khullar, Tiny Nair, et al.
Pageof 2